Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00357799 · ClinicalTrials.gov registry record · Phase 2
VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access
A Phase 2 study of Catheterization, Peripheral and Phlebotomy, sponsored by Children's Hospital and Health System Foundation, Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT00357799: Completed Phase 2 study of Catheterization, Peripheral and Phlebotomy, sponsored by Children's Hospital and Health System Foundation, Wisconsin.
NCT00357799 is a Phase 2 study of Catheterization, Peripheral and Phlebotomy that has completed, run by Children's Hospital and Health System Foundation, Wisconsin. The registered enrollment target is 170 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00357799, a Phase 2 study of Catheterization, Peripheral and Phlebotomy, has completed, sponsored by Children's Hospital and Health System Foundation, Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: The first attempt success rate for peripheral IV insertion for children with difficult IV access (difficult IV access \[DIVA\] score ≥ 4) by nurses using the VeinViewer guided technique is better than conventional method of IV placement. Specific Aims: 1. To investigate if use of the VeinViewer can improve the success of peripheral IV placement in children with difficult IV access 2. To validate the DIVA score Design: Prospective randomized controlled trial/Convenience sample Subjects: Children (0-18) presenting to the emergency department who require an IV as determined by examining physician and with a DIVA score ≥ 3 during times when VeinViewer machine is available and a VeinViewer trained participating nurse is on duty. Variables: Outcome Variables: First IV attempt success rate Predictor Variables: IV technique used, other potential modifiers (age, weight, height, skin shade, indication for IV, history of prematurity and, vein visibility/palpability after tourniquet) Methods: Subjects who meet inclusion criteria will be randomized to either conventional IV technique or VeinViewer guided technique. The nurse will attempt the IV depending on the randomization. Success or failure on first IV attempt will be recorded. If unsuccessful, other attempts will be tried until a successful IV is placed or the physician decides to give an alternative therapy that does not need IV access. Statistics: A chi square test will be used to compare the proportion of subjects with successful first attempt IV placement using the VeinViewer technique to that using the conventional method with 95% confidence interval. We, the researchers, will look at the median number of attempts to place an IV in each of the groups. Logistic regression will be performed to test for independent associations. Information collected during the study will also be used for validation of the DIVA score. Risks: No extra risks are expected above that of receiving a standard IV. The stand
Conditions Studied
Interventions
- DEVICE VeinViewer
Study Locations (1)
Wisconsin
- Children's Hospital of Wisconsin Emergency Department and Trauma Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
What the finished NCT00357799 record still lists
NCT00357799 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher).
The record links to 2 conditions, with Catheterization, Peripheral appearing as the primary indexed condition, and to 1 intervention - of which VeinViewer is the first listed.
NCT00357799 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00357799 about?
NCT00357799 is a clinical study titled "VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access". Hypothesis: The first attempt success rate for peripheral IV insertion for children with difficult IV access (difficult IV access \[DIVA\] score ≥ 4) by nurses using the VeinViewer guided technique is better than conventional method of IV placement. Specific Aims: 1. To investigate if use of the V...
What is the current status of trial NCT00357799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2006-10. Estimated completion is 2010-10.
What conditions does trial NCT00357799 study?
This clinical trial studies the following conditions: Catheterization, Peripheral, Phlebotomy.
What interventions are being tested in trial NCT00357799?
The interventions under investigation include: VeinViewer (DEVICE).
Who is sponsoring clinical trial NCT00357799?
This trial is sponsored by Children's Hospital and Health System Foundation, Wisconsin, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00357799 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheterization, Peripheral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00357799's enrollment target sits among peer trials
170 399th of 2000 higher than 1,598 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia